1. Home
  2. ROG vs AGIO Comparison

ROG vs AGIO Comparison

Compare ROG & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rogers Corporation

ROG

Rogers Corporation

HOLD

Current Price

$142.83

Market Cap

2.6B

Sector

Technology

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$33.53

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROG
AGIO
Founded
1832
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.3B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
ROG
AGIO
Price
$142.83
$33.53
Analyst Decision
Strong Buy
Buy
Analyst Count
1
8
Target Price
$133.00
$38.88
AVG Volume (30 Days)
230.2K
1.2M
Earning Date
04-28-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
$879,091,000.00
$43,011,000.00
Revenue This Year
$7.64
$76.75
Revenue Next Year
$6.09
$170.73
P/E Ratio
$550.84
N/A
Revenue Growth
7.07
N/A
52 Week Low
$72.49
$22.24
52 Week High
$169.00
$46.00

Technical Indicators

Market Signals
Indicator
ROG
AGIO
Relative Strength Index (RSI) 58.32 45.72
Support Level $130.83 $26.16
Resistance Level $144.46 $36.07
Average True Range (ATR) 5.79 1.79
MACD 2.19 0.01
Stochastic Oscillator 95.57 50.06

Price Performance

Historical Comparison
ROG
AGIO

About ROG Rogers Corporation

Rogers Corp designs develop and manufactures engineered materials and components for sale to original equipment manufacturers and component suppliers. The firm operates in three business segments: Advanced Electronics Solutions, which manufactures circuit materials for applications in communications infrastructure, automotive, and consumer electronics markets; elastomeric material solutions, which provide cushioning, sealing, and impact protection in automotive, transportation, and construction applications; and Other, which consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: